Skip to content

    Vanda Pharmaceuticals (VNDA) stock price & financials

    View VNDA earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+14.5% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $47.65M
    $53.19M
    $50.04M
    $52.59M
    $56.26M
    +18.1%
    $57.22M
    +7.6%
    $51.72M
    +3.4%
    $50.53M
    -3.9%
    Stable
    Operating Profit
    -$11.00M
    -$10.28M
    -$41.03M
    -$38.50M
    -$31.28M
    -184.4%
    -$40.35M
    -292.6%
    -$50.22M
    -22.4%
    -$63.81M
    -65.7%
    Weakening
    Net Profit
    -$5.32M
    -$4.91M
    -$29.49M
    -$27.21M
    -$22.59M
    -324.2%
    -$141.19M
    -2774.3%
    -$48.57M
    -64.7%
    -$62.51M
    -129.8%
    Weakening
    EPS
    $-0.09
    $-0.50
    $-0.46
    $-0.38
    -322.2%
    $-0.82
    -64.0%
    $-1.04
    -126.1%
    Weakening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    -$6.24M
    -$6.50M
    -$37.37M
    -$34.89M
    -$28.39M
    -354.7%
    -$38.00M
    -484.9%
    -$48.42M
    -29.6%
    -$62.38M
    -78.8%
    Weakening
    MarginsOPM
    -23.1%
    -19.3%
    -82.0%
    -73.2%
    -55.6%
    -140.9%
    -70.5%
    -264.9%
    -97.1%
    -18.4%
    -126.3%
    -72.5%
    Weakening
    Tax
    14.7%
    24.4%
    21.1%
    22.0%
    20.4%
    +38.8%
    -271.5%
    -1212.8%
    -0.3%
    -101.4%
    -0.2%
    -101.0%
    Weakening
    ReturnsROIC
    1.1%
    1.0%
    5.8%
    5.4%
    4.5%
    +324.2%
    27.9%
    +2774.3%
    9.6%
    +64.7%
    12.4%
    +129.8%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$61.01M$45.07M$61.03M$52.07M$135.03M$135.82M$102.32M$84.85M$55.88M
    Short-Term Investments
    Total Current Assets$299.13M$354.14M$409.14M$478.30M$519.29M$432.95M$438.89M$347.26M$264.48M
    Net PP&E$4.42M$15.04M$14.60M$12.38M$10.97M$9.14M$7.73M$6.17M$17.18M
    Goodwill
    Intangibles$24.54M$23.04M$21.56M$20.08M$18.57M$121.37M$114.10M$117.09M$113.11M
    Total Assets$332.13M$483.75M$533.46M$593.79M$634.25M$648.44M$656.20M$488.95M$412.47M
    LiabilitiesTotal Current Liabilities$53.02M$59.51M$65.94M$74.42M$91.44M$87.70M$99.98M$145.16M$164.03M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$0$12.46M$11.50M$10.05M$8.81M$7.01M$4.94M$2.99M$15.03M
    Total Liabilities$56.71M$72.80M$80.19M$88.86M$107.05M$103.53M$117.66M$161.76M$192.28M
    EquityCommon Stock & APIC$52.0K$54.0K$55.0K$56.0K$57.0K$58.0K$58.0K$59.0K$60.0K
    Retained Earnings-$336.22M-$220.66M-$197.33M-$164.18M-$157.90M-$155.39M-$174.29M-$394.77M-$505.85M
    Total Equity$275.42M$410.94M$453.27M$504.93M$527.20M$544.91M$538.55M$327.19M$220.19M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$29.99M$45.95M$51.77M$64.21M$31.98M$12.80M-$15.76M-$109.44M-$142.33M
    Cash from Investing-$109.66M-$68.31M-$41.50M-$76.70M$49.92M-$12.06M-$17.43M$94.86M$120.27M
    Cash from Financing$107.13M$6.26M$5.63M$3.55M$734.0K$0-$155.0K-$2.91M-$2.79M
    SummaryCapital Expenditure-$368.0K-$1.02M-$1.79M-$552.0K-$679.0K-$383.0K-$490.0K-$998.0K-$674.0K
    Free Cash Flow$29.62M$44.93M$49.98M$63.66M$31.30M$12.42M-$16.25M-$110.44M-$143.00M
    FCF Margin15.3%19.8%20.1%23.7%12.3%6.4%-8.2%-51.1%-66.3%

    Ratios